Fluent Corp. (CNTMF)
0.039
0.00 (0.00%)
USD |
OTCM |
Feb 19, 16:00
Fluent EPS Diluted (Quarterly) : -0.0225 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.59M |
| Revenue (Quarterly) | 26.04M |
| Total Expenses (Quarterly) | 39.62M |
| Enterprise Value | 165.57M |
| Gross Profit Margin (Quarterly) | 25.48% |
| Profit Margin (Quarterly) | -52.18% |
| Earnings Yield | -367.9% |
| Normalized Earnings Yield | 32.31 |